Literature DB >> 23229885

N0/N1, PNL, or LNR? The effect of lymph node number on accurate survival prediction in pancreatic ductal adenocarcinoma.

Nakul P Valsangkar1, Devon M Bush, James S Michaelson, Cristina R Ferrone, Jennifer A Wargo, Keith D Lillemoe, Carlos Fernández-del Castillo, Andrew L Warshaw, Sarah P Thayer.   

Abstract

INTRODUCTION: We evaluated the prognostic accuracy of LN variables (N0/N1), numbers of positive lymph nodes (PLN), and lymph node ratio (LNR) in the context of the total number of examined lymph nodes (ELN).
METHODS: Patients from SEER and a single institution (MGH) were reviewed and survival analyses performed in subgroups based on numbers of ELN to calculate excess risk of death (hazard ratio, HR).
RESULTS: In SEER and MGH, higher numbers of ELN improved the overall survival for N0 patients. The prognostic significance (N0/N1) and PLN were too variable as the importance of a single PLN depended on the total number of LN dissected. LNR consistently correlated with survival once a certain number of lymph nodes were dissected (≥13 in SEER and ≥17 in the MGH dataset).
CONCLUSIONS: Better survival for N0 patients with increasing ELN likely represents improved staging. PLN have some predictive value but the ELN strongly influence their impact on survival, suggesting the need for a ratio-based classification. LNR strongly correlates with outcome provided that a certain number of lymph nodes is evaluated, suggesting that the prognostic accuracy of any LN variable depends on the total number of ELN.

Entities:  

Mesh:

Year:  2012        PMID: 23229885      PMCID: PMC3806050          DOI: 10.1007/s11605-012-1974-7

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  37 in total

1.  Pattern analysis of lymph node metastasis and the prognostic importance of number of metastatic nodes in ampullary adenocarcinoma.

Authors:  Jae Hoon Lee; Kyeong Geun Lee; Tae Kyung Ha; Young Jin Jun; Seung Sam Paik; Hwon Kyum Park; Kwang Soo Lee
Journal:  Am Surg       Date:  2011-03       Impact factor: 0.688

Review 2.  Current opinion on lymphadenectomy in pancreatic cancer surgery.

Authors:  Theodoros E Pavlidis; Efstathios T Pavlidis; Athanasios K Sakantamis
Journal:  Hepatobiliary Pancreat Dis Int       Date:  2011-02

3.  Practical usefulness of lymphatic and connective tissue clearance for the carcinoma of the pancreas head.

Authors:  O Ishikawa; H Ohhigashi; Y Sasaki; T Kabuto; I Fukuda; H Furukawa; S Imaoka; T Iwanaga
Journal:  Ann Surg       Date:  1988-08       Impact factor: 12.969

4.  Radical pancreatectomy for ductal cell carcinoma of the head of the pancreas.

Authors:  T Manabe; G Ohshio; N Baba; T Miyashita; N Asano; K Tamura; K Yamaki; A Nonaka; T Tobe
Journal:  Cancer       Date:  1989-09-01       Impact factor: 6.860

5.  Long-term results of partial pancreaticoduodenectomy for ductal adenocarcinoma of the pancreatic head: 25-year experience.

Authors:  Axel Richter; Marco Niedergethmann; Jörg W Sturm; Dietmar Lorenz; Stefan Post; Michael Trede
Journal:  World J Surg       Date:  2003-02-27       Impact factor: 3.352

6.  Prognostic nomogram for patients undergoing resection for adenocarcinoma of the pancreas.

Authors:  Murray F Brennan; Michael W Kattan; David Klimstra; Kevin Conlon
Journal:  Ann Surg       Date:  2004-08       Impact factor: 12.969

7.  The metastatic/examined lymph node ratio is an important prognostic factor after pancreaticoduodenectomy for pancreatic adenocarcinoma.

Authors:  Adam C Berger; James C Watson; Eric A Ross; John P Hoffman
Journal:  Am Surg       Date:  2004-03       Impact factor: 0.688

8.  Prognostic factors following curative resection for pancreatic adenocarcinoma: a population-based, linked database analysis of 396 patients.

Authors:  Jonathan E Lim; Michael W Chien; Craig C Earle
Journal:  Ann Surg       Date:  2003-01       Impact factor: 12.969

9.  Curative resection is the single most important factor determining outcome in patients with pancreatic adenocarcinoma.

Authors:  M Wagner; C Redaelli; M Lietz; C A Seiler; H Friess; M W Büchler
Journal:  Br J Surg       Date:  2004-05       Impact factor: 6.939

10.  Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma, part 2: randomized controlled trial evaluating survival, morbidity, and mortality.

Authors:  Charles J Yeo; John L Cameron; Keith D Lillemoe; Taylor A Sohn; Kurtis A Campbell; Patricia K Sauter; JoAnn Coleman; Ross A Abrams; Ralph H Hruban
Journal:  Ann Surg       Date:  2002-09       Impact factor: 12.969

View more
  48 in total

Review 1.  Prognostic factors related with survival in patients with pancreatic adenocarcinoma.

Authors:  Ahmet Bilici
Journal:  World J Gastroenterol       Date:  2014-08-21       Impact factor: 5.742

2.  Clinical and pathologic features influencing survival in patients undergoing pancreaticoduodenectomy for pancreatic adenocarcinoma.

Authors:  Cynthia E Weber; Eileen A Bock; Michael G Hurtuk; Gerard J Abood; Jack Pickleman; Margo Shoup; Gerard V Aranha
Journal:  J Gastrointest Surg       Date:  2013-11-23       Impact factor: 3.452

Review 3.  Mesopancreas: A boundless structure, namely the rationale for dissection of the paraaortic area in pancreaticoduodenectomy for pancreatic head carcinoma.

Authors:  Nadia Peparini
Journal:  World J Gastroenterol       Date:  2015-03-14       Impact factor: 5.742

4.  Optimal Extent of Superior Mesenteric Artery Dissection during Pancreaticoduodenectomy for Pancreatic Cancer: Balancing Surgical and Oncological Safety.

Authors:  Yosuke Inoue; Akio Saiura; Atsushi Oba; Shoji Kawakatsu; Yoshihiro Ono; Takafumi Sato; Yoshihiro Mise; Takeaki Ishizawa; Yu Takahashi; Hiromichi Ito
Journal:  J Gastrointest Surg       Date:  2018-10-10       Impact factor: 3.452

5.  Timing But Not Patterns of Recurrence Is Different Between Node-negative and Node-positive Resected Pancreatic Cancer.

Authors:  Kim C Honselmann; Ilaria Pergolini; Carlos Fernandez-Del Castillo; Vikram Deshpande; David Ting; Martin S Taylor; Louisa Bolm; Motaz Qadan; Ulrich Wellner; Marta Sandini; Dirk Bausch; Andrew L Warshaw; Keith D Lillemoe; Tobias Keck; Cristina R Ferrone
Journal:  Ann Surg       Date:  2019-01-18       Impact factor: 12.969

6.  Extended lymphadenectomy in pancreatic cancer is crucial.

Authors:  Tsutomu Fujii
Journal:  World J Surg       Date:  2013-08       Impact factor: 3.352

7.  Prognostic Value of Metastatic Lymph Node Ratio in Pancreatic Cancer.

Authors:  Can A Karaca; Ahmet Coker
Journal:  Indian J Surg Oncol       Date:  2018-10-26

8.  Accurate prediction of nodal status in preoperative patients with pancreatic ductal adenocarcinoma using next-gen nanoparticle.

Authors:  Shaunagh McDermott; Sarah P Thayer; Carlos Fernandez-Del Castillo; Mari Mino-Kenudson; Ralph Weissleder; Mukesh G Harisinghani
Journal:  Transl Oncol       Date:  2013-12-01       Impact factor: 4.243

9.  MicroRNA Expression in a Readily Accessible Common Hepatic Artery Lymph Node Predicts Time to Pancreatic Cancer Recurrence Postresection.

Authors:  Hai V Nguyen; Jesse Gore; Xin Zhong; Sudha S Savant; Samantha Deitz-McElyea; C Max Schmidt; Michael G House; Murray Korc
Journal:  J Gastrointest Surg       Date:  2016-07-25       Impact factor: 3.452

10.  Extended lymphadenectomy in patients with pancreatic cancer is debatable.

Authors:  Gregory Sergeant; Emmanuel Melloul; Mickael Lesurtel; Michelle L Deoliveira; Pierre-Alain Clavien
Journal:  World J Surg       Date:  2013-08       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.